A Streamlined Scientific Approach To Primary Packaging Solutions For Biologics

The selection of the appropriate primary packaging for an injectable drug product is one of the most crucial considerations in the drug development process – the wrong choice can cost significant time and resources. The increasing number of complex and sensitive biologics is only adding to the pressure to get it right first time.

A particular challenge when it comes to biologics is the issue of sensitivity. It has always been a problem for the pharmaceutical industry, but it is even more of an issue now that more drugs are biologics and highly concentrated. By some estimates, 20-30% of drug formulations now have sensitivity issues – reacting to one or more elements of their primary packaging and losing their stability.